Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
The DOI matches its Crossref record, with a small difference in title or year; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The ubiquitination of the hypoxia-inducible factor (HIF) by the von Hippel–Lindau tumor suppressor (pVHL) plays a central role in the cellular response to changes in oxygen availability. pVHL binds to HIF only when a conserved proline in HIF is hydroxylated, a modification that is oxygen-dependent. The 1.85 angstrom structure of a 20-residue HIF-1α peptide–pVHL–ElonginB–ElonginC complex shows that HIF-1α binds to pVHL in an extended β strand–like conformation. The hydroxyproline inserts into a gap in the pVHL hydrophobic core, at a site that is a hotspot for tumorigenic mutations, with its 4-hydroxyl group recognized by buried serine and histidine residues. Although the β sheet–like interactions contribute to the stability of the complex, the hydroxyproline contacts are central to the strict specificity characteristic of signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The subsequent discovery of a peptide from hypoxia-inducible factor 1 subunit-α (HIF1α) that bound the E3 ligase von Hippel–Lindau tumour suppressor (VHL)18,19 led to the design of cell-penetrating PROTACs that degraded a range of POIs.”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [19]
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Self-citationA conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Self-citationSCF and Cullin/RING H2-Based Ubiquitin Ligases
Deshaies, R. J. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.435 · Cited by 1,242
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014
Structural Basis of Collagen Recognition by Integrin α2β1
Emsley, J., Knight, C. G., Farndale, R. W., Barnes, M. J., & Liddington, R. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80622-4 · Cited by 1,005
Research works printed but not linked: 2
- A. Pause et al. Proc. Natl. Acad. Sci. U.S.A. 94 2156 (1997).
- We thank P. Jeffrey for help with data collection and processing C. E. Stebbins and the members of the Pavletich lab for helpful discussions C. Murray and M. Minto for administrative assistance J. Crawford for peptide synthesis and the staff of the Cornell High Energy Synchrotron Source for help with data collection. This work was supported by the NIH the Howard Hughes Medical Institute the Dewitt Wallace Foundation the Samuel and May Rudin Foundation and the Arthur and Rochelle Belfer Foundation. Coordinates have been deposited in the RCSB Protein Data Bank (accession code 1LM8). Supporting Online Material www.sciencemag.org/cgi/content/full/1073440/DC1 Materials and Methods SFigs. 1 to S4
Cited by
Items 601–700 of 865
Destabilization of HIF-1a by Diabetes, Oxidative Stress, Obesity and Other Related Disorders
Karavasilis, A., Καρκαλούσος, Π., Trapali, M., Fountzoula, C., & Karikas, G. A. (2023) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2023.132012 · Cited by 6
Genotype-phenotype correlation of ocular von Hippel-Lindau disease in Koreans
Hwang, S., Kang, S. W., Kim, J.-W., & Kim, S. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311665 · Cited by 6
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma
D'Elia, A. V., Grimaldi, F., Pizzolitto, S., Maglio, G. D., Bregant, E., Passon, N., Franzoni, A., Verrienti, A., Tamburrano, G., Durante, C., et al. (2012) · Clinical Endocrinology · doi:10.1111/cen.12032 · Cited by 6
Sonoda, K., Bogahawaththa, S., Katayama, A., Ujike, S., Kuroki, S., Kitagawa, N., Hirotsuru, K., Suzuki, N., Miyata, T., Kawaguchi, S.-I., et al. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00002 · Cited by 6
Screening of prolyl hydroxylase 2 inhibitors based on quantitative strategy of peptides
Zhang, Y., Nsanzamahoro, S., Wang, C., Wang, W., & Yang, J. (2022) · Journal of Chromatography A · doi:10.1016/j.chroma.2022.463411 · Cited by 6
Palacios, D. S. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01491 · Cited by 6
Von Hippel-Lindau disease type 2 in a Chinese family with a VHL p.W88X truncation
Zhang, M., Wang, J., Jiang, J., Zhan, X., Ling, Y., Lu, Z., Guo, J., & Gao, X. (2014) · Endocrine · doi:10.1007/s12020-014-0368-x · Cited by 6
Chen, H., Lin, G., Sui, Q., & Lin, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123347 · Cited by 6
Kim, S. Y., Lee, M. J., Kim, J. W., Na, Y.-R., Lee, H., Cho, H.-J., Lee, K. B., Lee, Y. M., Lee, C., Park, H., et al. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00507 · Cited by 6
Lights on for HIF-1a: Genetically Enhanced Mouse Cardiomyocytes for Heart Tissue Imaging
Hesse, A., Levent, E., Zieseniß, A., Tiburcy, M., Zimmermann, W., & Katschinski, D. M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363014 · Cited by 6
Gala, D., Mohak, S., & Fábián, Z. (2021) · Cells · doi:10.3390/cells10092199 · Cited by 6
Adventures in Defining Roles of Oxygenases in the Regulation of Protein Biosynthesis
Walport, L. J., & Schofield, C. J. (2018) · The Chemical Record · doi:10.1002/tcr.201800056 · Cited by 6
Engineering Polymeric Nano-PROTAC for Targeted Protein Degradation and Cancer Therapy
Saeed, M., Amina, Z., Xu, Z., & Yu, H. (2026) · Polymer science & technology. · doi:10.1021/polymscitech.5c00122 · Cited by 5
Heritable and Syndromic Pheochromocytoma and Paraganglioma
Kopp, P. A. (2018) · Contemporary Endocrinology · doi:10.1007/978-3-319-77048-2_4 · Cited by 5
Lolkema, M. P., & Voest, E. E. (2008) · Springer eBooks · doi:10.1007/978-1-84628-763-3_14 · Cited by 5
Belato, F. A., Mello, B., Coates, C. J., Halanych, K. M., Brown, F. D., Morandini, A. C., Leme, J. D. M., Trindade, R. I. F., & Costa-Paiva, E. M. (2023) · Geobiology · doi:10.1111/gbi.12577 · Cited by 5
Chu, X., Zhu, C., Liu, H., & Wang, J. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.14.5819 · Cited by 5
Dong, X., Su, X., Yu, J., Liu, J., Shi, X., Pan, Q., Yang, J., Chen, J., Li, L., & Cao, H. (2016) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2016.11.011 · Cited by 5
Early Events in Diabetic Retinopathy and Intervention Strategies
Tsin, A. T. C., & Grigsby, J. G. (2018) · InTech eBooks · doi:10.5772/intechopen.69906 · Cited by 5
Kudo, Y., Kakinuma, Y., Iguchi, M., Sato, T., Sugiura, T., Furihata, M., & Shuin, T. (2007) · Nephron Experimental Nephrology · doi:10.1159/000103022 · Cited by 5
REGULATION OF TRANSCRIPTION FACTOR ACTIVITY
Latchman, D. S. (2008) · Elsevier eBooks · doi:10.1016/b978-012373983-4.50016-x · Cited by 5
Loenarz, C. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201913263 · Cited by 5
Islam, M. S., & Jesmin, J. (2024) · Biomarker Insights · doi:10.1177/11772719241278176 · Cited by 4
Drug Design Methods to Regulate Protein–Protein Interactions
Poluri, K. M., Gulati, K., Tripathi, D. K., & Nagar, N. (2023) · Springer eBooks · doi:10.1007/978-981-99-2423-3_6 · Cited by 4
Drugit: crowd-sourcing molecular design of non-peptidic VHL binders
Scott, T., Smethurst, C. A., Westermaier, Y., Mayer, M., Greb, P., Kousek, R., Biberger, T., Bader, G., Jandová, Z., Schmalhorst, P. S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58406-0 · Cited by 4
A novel mutation in the VHL gene in a Chinese family with von Hippel-Lindau disease
Wu, X., Chen, L., Zhang, Y., Xie, H., Xue, M., Wang, Y., & Huang, H. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0716-4 · Cited by 4
Kumar, V., Kaushik, V., Kumar, S., Levkovich, S. A., Gupta, P., Bar‐Yosef, D. L., Gazit, E., & Segal, D. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149250 · Cited by 4
Molecular Biology of Iron in Nutritional Science.
Fujita, H., Nishitani, C., & NAKAJIMA, M. (2003) · Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene) · doi:10.1265/jjh.58.248 · Cited by 4
In Silico Tools in PROTACs designPreprint
Wei, M. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2307.01320 · Cited by 4
Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (p97-PROTAC)
Salinas-Rebolledo, C., Blesa, J., Valenzuela-Nieto, G., Schwefel, D., López-González del Rey, N., Méndez-Ruette, M., Burkhalter, J., Carrazana, E., Díaz-Tejeda, F., Arias Catalán, I., et al. (2025) · eLife · doi:10.7554/elife.101496 · Cited by 3
Targeting the Spliceosomal Protein USP39 Through Allosteric Ligands and PROTAC‐Induced Degradation
Schäfer, D., Prieto‐Garcia, C., Wang, J., Heinz, M., Matković, V., Kielkowski, P., Hasselbeck, S., Shah, V. J., Knapp, S., Hummer, G., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202516809 · Cited by 3
Vollmer, L. L., Roberts, P., Eicher, S. L., Wołosowicz, M., Patel, P., Figura, J. R., Donahue, E. R., Berkowitz, J., Gavlock, D. C., Wipf, P., et al. (2025) · SLAS DISCOVERY · doi:10.1016/j.slasd.2025.100278 · Cited by 3
Kim, S. Y., Lee, M. J., Na, Y., Kim, S.-Y., & Yang, E. G. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24659 · Cited by 3
Antioxidant and antihypoxic properties of neuroprotective drugs
Poloznikov, A. A., Smirnova, N. A., Khristichenko, A. Y., Hushpulian, D. M., Nikulin, S. V., Tishkov, V. I., Gaisina, I. N., & Gazaryan, I. G. (2016) · Russian Chemical Bulletin · doi:10.1007/s11172-016-1687-2 · Cited by 3
Shi, M., Zhou, X., Cai, Y., Li, P., Qin, D., Yan, X., Du, M., Li, S., & Xu, D. (2021) · Chinese Journal of Chemical Physics · doi:10.1063/1674-0068/cjcp2110198 · Cited by 3
Mathó, C., Fernández, M. C., Bonanata, J. N., Liu, X.-D., Martín, A., Vieites, A., Sansó, G., Barontini, M., Jonasch, E. W., Coitiño, E. L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.854365 · Cited by 3
Mohammed, A., Mamoojee, Y. H., & Quinton, R. (2024) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2024.101930 · Cited by 3
Inherited and Somatic Genetics of Pancreatic Neuroendocrine Tumors
Fishbein, L. M., & Nathanson, K. L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1798-3_2 · Cited by 3
Structural and Biophysical Principles of Degrader Ternary Complexes
Zollman, D., & Ciulli, A. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160691-00014 · Cited by 3
Cellular Principles of Targeted Protein Degradation
Diamantino, J., & Hellerschmied, D. (2022) · Wiley eBooks · doi:10.1002/9783527836208.ch2 · Cited by 3
ATF4 and HIF-1α in bone: An intriguing relationship
Schipani, E., Mangiavini, L., & Merceron, C. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2045 · Cited by 3
Clinical presentation and mutation analysis of VHL disease in a large Chinese family
Zhang, Q. H., Li, D., Kang, P., Ji, N., Yang, J. J. J., Liu, W., Zhang, L., & Jia, G. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1924-9 · Cited by 3
Hypoxia-Inducible Factor-1 Signaling System
Stroka, D., & Candinas, D. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_27 · Cited by 3
Hypoxia and the hypoxia-inducible factors in the skeleton
Schipani, E., & Clemens, T. L. (2008) · IBMS BoneKEy · doi:10.1138/20080329 · Cited by 3
Identification of a VHL gene mutation in a Chinese family with Von Hippel‑Lindau syndrome
He, Z., Xia, L., Deng, Z., Lian, A., Hu, Z., & Li, B. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8974 · Cited by 3
VHL L169P Variant Does Not Alter Cellular Hypoxia Tension in Clear Cell Renal Cell Carcinoma
Hu, J., Smith, D., & Wu, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814075 · Cited by 3
The recruitment of exogenous endothelial progenitor cells in lung tumor model of nude mice
Peng, Q., Liu, M., Song, S.-M., Li, X., Du, Y., Zhi, Y., & Wang, M.-Y. (2010) · 癌症:英文版 · doi:10.5732/cjc.010.10194 · Cited by 3
Molecular Biology of Kidney Cancer
Kaelin, W. G. (2011) · Springer eBooks · doi:10.1007/978-3-642-21858-3_3 · Cited by 3
Self-citationLoenarz, C., Chowdhury, R., Schofield, C. J., & Flashman, E. (2008) · Pure and Applied Chemistry · doi:10.1351/pac200880081837 · Cited by 3
Pheochromocytoma and Paraganglioma
Robledo, M., Currás, M., & Cascón, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-74448-9_5 · Cited by 3
Longrois, D., & Mertès, P. (2010) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(10)70435-7 · Cited by 3
Zhu, L., Ding, R., Yan, H., Zhang, J., & Lin, Z. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03678-9 · Cited by 3
Testa, A., Lucas, X., Castro, G. V., Chan, K.-H., Wright, J. E., Runcie, A. C., Gadd, M. S., Harrison, W. T. A., Ko, E.-J., Fletcher, D., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b03833 · Cited by 3
Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (PROTAC)
Salinas-Rebolledo, C., Blesa, J., Valenzuela-Nieto, G., Schwefel, D., del Rey, N. L. G., Méndez-Ruette, M., Burkhalter, J., Bátiz, L. F., Jara, R., Obeso, J. A., et al. (2024) · doi:10.1101/2024.03.08.584142 · Cited by 3
NMR-Based Fragment Screen of the von Hippel-Lindau Elongin C&B Complex
Amporndanai, K., Katinas, J. M., Chopra, A., Kayode, O., Vadukoot, A. K., Waterson, A. G., & Fesik, S. W. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00316 · Cited by 2
Protacs Targeting ERα in the Effective Management of Endocrinal Resistance Breast Cancer
Singh, A., Khan, R., Erachampatt, N. A., Bhatia, N., Monga, V., & Thareja, S. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70176 · Cited by 2
Molecular glues and PROTACs: unlocking targeted protein degradation in plant biology
Donderis-Fagoaga, C., Orea-Ordóñez, L., & Lozano‐Juste, J. (2026) · Journal of Experimental Botany · doi:10.1093/jxb/erag256 · Cited by 2
Analysis of von Hippel–Lindau Tumor Suppressor as a Mediator of Cellular Oxygen Sensing
Masson, N., & Ratcliffe, P. J. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)81021-8 · Cited by 2
Gossage, L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1622-1_4 · Cited by 2
The Role of Angiogenesis in the Development of Psoriasis
Arruda, A. C. B. B., Siqueira, D. M., & Mercadante, L. M. (2017) · Springer eBooks · doi:10.1007/978-1-4471-7314-4_3 · Cited by 2
Characterization of the pVHL Interactome in Human Testis Using High-Throughput Library Screening
Falconieri, A., Minervini, G., Quaglia, F., Sartori, G., & Tosatto, S. C. E. (2022) · Cancers · doi:10.3390/cancers14041009 · Cited by 2
Duan, L., Jiang, Y., Shi, Y., & Fong, G. (2023) · Biology Open · doi:10.1242/bio.059684 · Cited by 2
Research progress on oncoprotein hepatitis B X‑interacting protein (Review)
Cheng, L., Guo, L., Zou, T., Yang, Y., Tao, R., & Liu, S. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13213 · Cited by 2
Promoting a Cobalt Complex of Qingzhuan Dark Tea Polysaccharides on Fracture Healing in Rats
Zheng, M. H., Chen, Y., Wang, Z., Xie, C., Zhou, C., Wang, L., Xiong, F., Li, L., Xing, J., Wang, C., et al. (2024) · Tissue Engineering Part A · doi:10.1089/ten.tea.2023.0125 · Cited by 2
Therapeutic Strategies that Target the HIF System
Cook, K. M., & Schofield, C. J. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_32 · Cited by 2
Fukui, N., Kageyama, Y., Higashi, Y., Kihara, K., Kizaka‐Kondoh, S., Hiraoka, M., Shinojima, T., Suzuki, K., & Oya, M. (2013) · International Journal of Clinical Oncology · doi:10.1007/s10147-013-0568-z · Cited by 2
Regulation of endogenous erythropoietin production
Mole, D. R., & Ratcliffe, P. J. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8698-6_2 · Cited by 2
Zhang, F., Shi, Y., Li, C., & Song, H. (2011) · Communications in Theoretical Physics · doi:10.1088/0253-6102/56/2/33 · Cited by 2
Arunachal, G., Pachat, D., Doss, C. G. P., Danda, S., Pai, R. B., & Ebenazer, A. (2016) · Genetics Research International · doi:10.1155/2016/9872594 · Cited by 2
The VHL short variant involves in protein quality control
Liu, Y., Yang, H., Zuo, F., & Chen, L. (2016) · Gene · doi:10.1016/j.gene.2016.05.027 · Cited by 2
Self-citationGas Tunnel Engineering of Prolyl Hydroxylase Reprograms Hypoxia Signaling in Cells
Windsor, P. K., Ouyang, H., da Costa, J. A. G., Damodaran, A. R., Chen, Y., & Bhagi‐Damodaran, A. (2024) · Angewandte Chemie · doi:10.1002/ange.202409234 · Cited by 2
The role of ascorbate in the regulation of HIF-1 in cancer cells
Kuiper, C. (2013) · Otago University Research Archive (University of Otago) · Cited by 2
Controlled Oxygen Activation in Human Oxygen Sensor FIH
Saban, E. (2011) · Scholarworks (University of Massachusetts Amherst) · doi:10.7275/2395887 · Cited by 2
Mitochondrial modulators of hypoxia-related pathways in tumours
Snell, C. E. (2013) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-aememajj6 · Cited by 2
Regulation of Transcription Factor Activity
Latchman, D. S. (2004) · Elsevier eBooks · doi:10.1016/b978-012437178-1/50014-x · Cited by 2
The Structural Biology of Ubiquitin–Protein Ligases
Zheng, N., & Pavletich, N. P. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch7 · Cited by 2
Self-citationChatterjee, S., Paul, N., Das, A., Bank, S., Bankura, B., Sarkar, K., Saha, S., Malakar, S., Choudhury, S., Ghosh, S., et al. (2025) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2024.12.266 · Cited by 1
Chatterjee, S., Paul, N., Das, A., Bank, S., Bankura, B., Yadav, R. P., Sarkar, K., Saha, S., Malakar, S., Choudhury, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-95875-1 · Cited by 1
S-nitrosylation of pVHL regulates β 2 adrenergic receptor function
Grimmett, Z. W., Hayashi, H., Raffay, T. M., Lin, J., Premont, R. T., & Stamler, J. S. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2515326122 · Cited by 1
Roles of E3 ubiquitin ligases and deubiquitinating enzymes in renal cell carcinoma
Jiang, M., Si, W., Huang, S., Qu, S., Zhang, M., & Quan, Y. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1628710 · Cited by 1
Advancing proteolysis targeting chimeras toward clinical drug developments
Tian, X., Huang, C., Yin, L., & Yu, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23932-8.00007-8 · Cited by 1
Whole-Genome Landscape of Retinal Hemangioblastomas
Bals, K., Hajjaj, A., van Overdam, K. A., Veckeneer, M., de Graaf, B. M., Eussen, B., Brands, T., Oldenburg, R. A., Alves, M. M., Verdijk, R. M., et al. (2026) · Translational Vision Science & Technology · doi:10.1167/tvst.15.1.5 · Cited by 1
AlphaFold2 ‐Guided Cyclic Peptide Stabilizer Design to Target Protein–Protein Interactions
Halbwedl, N., & Zacharias, M. (2026) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.70123 · Cited by 1
Jeong, Y. S., Shin, J.-H., Kim, S. M., Sohn, B. H., Yim, S. Y., Kim, J. H., Shim, J. J., Lee, S. H., Chun, Y. S., Lee, S. S., et al. (2026) · 癌症:英文版 · doi:10.34133/cancomm.0020 · Cited by 1
Potential Application of HIF-PH Inhibitors to Treat Kidney Diseases
Izumi, Y., Yasuoka, Y., Nanami, M., Kawahara, K., & Nonoguchi, H. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl47718 · Cited by 1
The Role of Hypoxia-Induced Factors
Schipani, E., & Khatri, R. (2010) · Springer eBooks · doi:10.1007/978-1-84882-822-3_7 · Cited by 1
Diagnostic Genetics at a Distance: Von Hippel-Lindau Disease and a Novel Mutation
Brookes, C., Prosser, D. O., Love, J. M., Gardner, R. J. M., & Love, D. R. (2013) · Genetics Research International · doi:10.1155/2013/189196 · Cited by 1
THE VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN AND KIDNEY CANCER
Kaelin, W. G., & Ma, B. (2007) · Medicina-buenos Aires · Cited by 1
Self-citationChen, Y., Huang, B., & Yang, C. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.10.009 · Cited by 1
Vikkath, N., Ariyannur, P. S., Menon, K. N., Bindhu, M. R., & Pillai, A. B. (2018) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2018-0007 · Cited by 1
The long form of pVHL is artifactually modified by serine protease inhibitor AEBSF
Tarade, D., He, S., St‐Germain, J. R., Petroff, A., Murphy, A., Raught, B., & Ohh, M. (2020) · Protein Science · doi:10.1002/pro.3898 · Cited by 1
VHL-Related Neuroendocrine Neoplasms And Beyond: An Israeli Specialized Center Real-Life Report
Szalat, A., Oleinikov, K., Nahmias, A., Meiner, V., Ben‐Haim, S., Atlan, K., Lev‐Cohain, N., Appelbaum, L., Gomori, M. J., Mazeh, H., et al. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0220 · Cited by 1
Evaluating Ligands for Ubiquitin Ligases Using Affinity Beads
Dobrodziej, J., Dong, H., Zimmermann, K., & Hickey, C. M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1665-9_4 · Cited by 1
Hypoxia-Inducible Factor-1 Signaling System
Stroka, D., & Candinas, D. (2005) · Springer eBooks · doi:10.1007/3-540-27194-5_26 · Cited by 1
Substrate recognition by Cullin-RING ubiquitin ligase and chemical intervention
Xu, C., Fan, X., Gao, X., & Qi, W. (2025) · Scientia Sinica Chimica · doi:10.1360/ssc-2024-0242 · Cited by 1
WITHDRAWN: Production of a novel UBE2S anti-body and significance of its expression in some tumors
Zhang, X., Liu, Q., Zhao, F., & Guo, D. (2014) · Pathology - Research and Practice · doi:10.1016/j.prp.2014.12.012 · Cited by 1
Subcellular localization of hypoxia-inducible factors and HIF regulatory hydroxylases in rat liver.
Khan, Z. (2006) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Protein Surface Recognition by Synthetic Molecules
Samanta, K., Jana, P., Hirschhäuser, C., & Schmuck, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12533-8 · Cited by 1
Role of HIF-1 in Brain Tumor Development
Shahi, M. H. (2023) · Springer eBooks · doi:10.1007/978-981-15-8473-2_13 · Cited by 1
Metadata
- Authors
- Min, J.-H., Yang, H., Ivan, M., Gertler, F., Kaelin, W. G., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Dana-Farber Cancer Institute (US)
- Massachusetts Institute of Technology (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Pavletich, Nikola P.
- Venue
- Science
- Published
- 2002-06-07
- Volume
- 296
- Issue
- 5574
- Pages
- 1886-1889
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2596045242
- Cited by
- 765
- References
- 25
- Citations by year
- 2026: 25 · 2025: 32 · 2024: 37 · 2023: 44 · 2022: 33 · 2021: 32 · 2020: 39 · 2019: 27 · 2018: 24 · 2017: 26 · 2016: 27 · 2015: 30 · 2014: 28 · 2013: 28 · 2012: 24
- FWCI
- 18.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIF-1α, VHL, hydroxylation, protein-protein complex structure, hypoxia signaling, tumor suppressor mutations, beta-strand conformation, oxygen sensing
- MeSH terms
- Elongin, Amino Acid Sequence, Animals, Binding Sites, Humans, Hydrogen Bonding, Hydroxylation, Hydroxyproline, Ligases, Models, Molecular, Molecular Sequence Data, Mutation, Protein Conformation, Transcription Factors, Signal Transduction, Protein Structure, Secondary, Protein Structure, Tertiary, Crystallography, X-Ray, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Macromolecular Substances, Mice, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.